American Century Companies’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
American Century Companies's MRNA Position: Q2 2026 in Review
American Century Companies increased its Moderna (MRNA) stake by 45% in Q2 2026, buying an estimated $1.77M and bringing the position to 110,860 shares worth $7.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1690.
American Century Companies first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $87.6M in Q2 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- American Century Companies held 110,860 shares of Moderna worth $7.76M as of Q2 2026.
- American Century Companies bought 34,173 Moderna shares in Q2 2026, an estimated $1.77M.
- Moderna made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1690 holding.
- American Century Companies first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
- American Century Companies's Moderna position peaked at $87.6M in Q2 2021.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.